Page 724«..1020..723724725726..730740..»

Part Two: The Ellis Martin Report – Interview with Ken Aldrich of International Stem Cell Corp.

By Dr. Matthew Watson

International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where Ellis Martin had the pleasure of interviewing Executive Chairman Kenneth Aldrich. 


International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regenerative cell therapy. Additionally, Lifeline Cell Technology, (a wholly-owned subsidiary of International Stem Cell Corporation (ISCO) develops, manufactures and markets high-quality human primary cells, stem cells, media and reagents for sale to pharmaceutical, academic and government scientists. 

The company's management pioneered the development of the normal human cell culture market through the creation of Clonetics® Corporation in the 1980s and has over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales of human cell culture products. Lifeline's products are distributed in the United States and Europe. http://www.ellismartinreport.comhttp://www.intlstemcell.com contact: martinreports@gmail.com 
International Stem Cell is a paid sponsor of The Ellis Martin Report

To Read More: Part Two: The Ellis Martin Report – Interview with Ken Aldrich of International Stem Cell Corp.
categoriaStem Cell Therapy commentoComments Off on Part Two: The Ellis Martin Report – Interview with Ken Aldrich of International Stem Cell Corp. | dataAugust 14th, 2011
Read All

The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.

By Dr. Matthew Watson

Your browser does not support the audio element.

Please click on the arrow above to listen to the complete interview.

"Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and Applications"

The Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where I have the pleasure of interviewing Executive Chairman, Kenneth Aldrich. International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regenerative cell therapy. Additionally, Lifeline Cell Technology, a wholly-owned subsidiary of International Stem Cell Corporation (ISCO), develops, manufactures and markets high-quality human primary cells, stem cells, media and reagents for sale to pharmaceutical, academic and government scientists. The company’s management pioneered the development of the normal human cell culture market through the creation of Clonetics® Corporation in the 1980s and has over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales of human cell culture products. Lifeline’s products are distributed in the United States and Europe. Ken Aldrich, welcome to the program.
For the complete text version of this broadcast: http://www.ellismartinreport.com/node/148

To Read More: The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp.
categoriaStem Cell Therapy commentoComments Off on The Ellis Martin Report: Interview with Ken Aldrich of International Stem Cell Corp. | dataAugust 14th, 2011
Read All

Reminder: International Stem Cell Holding Business Update Conference Call on August 10

By Dr. Matthew Watson

International Stem Cell Corporation (OTCBB:ISCO) reminds investors that it is holding a conference call and webcast on Wednesday, August 10, 2011 at 11:00 a.m. Eastern (8:00 a.m. Pacific). Chairman Ken Aldrich will provide an update on the business, including plans for the future development of the skin care line; animal and potential clinical trials for Parkinson's and liver diseases; and the Company's business strategy for 2011 and longer term.


Individuals interested in listening to the conference call may do so by dialing 877-407-8033 for domestic callers, or 201-689-8033 for international callers, or from the webcast on the investor relations section of the Company's Web site athttp://www.intlstemcell.com.


A telephone replay will be available approximately one hour after the conclusion of the call by dialing (877) 660-6853 for domestic callers, or 201-612-7415 for international callers, and entering the account code: 286 and the Conference ID: 376367. The webcast will be available on the Company's Web site for 60 days following the completion of the call.


About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.


To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.

International Stem Cell Corporation

Kenneth C. Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com

or:
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
dmarkley@lhai.com

To Read More: Reminder: International Stem Cell Holding Business Update Conference Call on August 10
categoriaStem Cell Therapy commentoComments Off on Reminder: International Stem Cell Holding Business Update Conference Call on August 10 | dataAugust 14th, 2011
Read All

Stroke Victim Improved With Stem Cell Therapy. More at http://www.stemcellfusion.com

By raymumme

See the original post here:
Stroke Victim Improved With Stem Cell Therapy. More at http://www.stemcellfusion.com

To Read More: Stroke Victim Improved With Stem Cell Therapy. More at http://www.stemcellfusion.com
categoriaUncategorized commentoComments Off on Stroke Victim Improved With Stem Cell Therapy. More at http://www.stemcellfusion.com | dataAugust 12th, 2011
Read All

Dr. Craig Saunders Adult Stem Cell Therapy

By Sykes24Tracey

Dr. Saunders is one of only a handful of doctors in the country who offer complete on-site adult stem cell retrieval, harvest, and adult stem cell therapy

Read more:
Dr. Craig Saunders Adult Stem Cell Therapy

To Read More: Dr. Craig Saunders Adult Stem Cell Therapy
categoriaUncategorized commentoComments Off on Dr. Craig Saunders Adult Stem Cell Therapy | dataAugust 11th, 2011
Read All

Stem Cells for Spinal Cord Injury: Community Outreach San Diego 2011 – Trish Stressman

By NEVAGiles23

Stem cell therapy patient Trish Stressman discusses her recovery from spinal cord injury after undergoing stem cell treatments at the Stem Cell Institute in Panama City, Panama.

Read this article:
Stem Cells for Spinal Cord Injury: Community Outreach San Diego 2011 - Trish Stressman

To Read More: Stem Cells for Spinal Cord Injury: Community Outreach San Diego 2011 – Trish Stressman
categoriaSpinal Cord Stem Cells commentoComments Off on Stem Cells for Spinal Cord Injury: Community Outreach San Diego 2011 – Trish Stressman | dataAugust 9th, 2011
Read All

Christian Drapeau Talk About – Adult Stem Cells and StemEnhance./StemTech

By Dr. Matthew Watson

Adult Stem Cells are present in your body from the day you are born and are naturally produced in your bone marrow. Stem cells can become virtually any type of cell in your body.

More:
Christian Drapeau Talk About - Adult Stem Cells and StemEnhance./StemTech

To Read More: Christian Drapeau Talk About – Adult Stem Cells and StemEnhance./StemTech
categoriaBone Marrow Stem Cells commentoComments Off on Christian Drapeau Talk About – Adult Stem Cells and StemEnhance./StemTech | dataAugust 7th, 2011
Read All

Review: Rise of the Planet of the Apes – Mirror.co.uk

By Dr. Matthew Watson


Sydney Morning Herald
Review: Rise of the Planet of the Apes
Mirror.co.uk
When his experiment in genetic engineering to find a cure for Alzheimer's goes wrong, scientist Will Rodman (Franco) is ordered to put down the chimps that have been tested on. But he decides to take home a baby one he calls ...
Rise of the Planet of the Apes: Best of the FranchiseThe New American
'Apes': Something to Thump Chests AboutWall Street Journal (blog)
Movie Review: Rise of the Planet of the ApesNew Zealand Herald
South Bend Tribune -International Business Times -Washington Times
all 1,839 news articles »

To Read More: Review: Rise of the Planet of the Apes – Mirror.co.uk
categoriaUncategorized commentoComments Off on Review: Rise of the Planet of the Apes – Mirror.co.uk | dataAugust 7th, 2011
Read All

A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview)

By Dr. Matthew Watson

In 1989 when scientists discovered the defective gene that causes cystic fibrosis, a serious hereditary disorder that primarily strikes children of European descent, it seemed as though a long-hoped-for cure might soon follow. After all, tests in many laboratories showed that providing normal copies of the gene should enable patients to make healthy copies of the protein specified by the gene. If successful, that feat would go a long way toward restoring health in the tens of thousands of people around the world who suffered from cystic fibrosis and typically died in their late 20s. (Half of all patients now live to their late 30s or beyond.) The question was whether researchers would be able to reliably insert the correct gene into the proper tissues in patients’ bodies to rid them of the illness forever.

That task proved harder than anyone had believed. Although scientists successfully engineered viruses to ferry copies of the correct gene into patients’ cells, the viruses did not do the job well. By the late 1990s additional unexpected complications made it increasingly obvious that another approach to addressing the fundamental problem in cystic fibrosis would need to be found.

[More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


To Read More: A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview)
categoriaUncategorized commentoComments Off on A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment (preview) | dataAugust 7th, 2011
Read All

International Stem Cell Corporation Chairman Ken Aldrich Interviewed by Ellis Martin

By Dr. Matthew Watson

"The Ellis Martin Report features interviews with exciting, potentially undervalued small and mid-cap publicly traded companies, showcased to an audience of potential retail investors during market hours throughout the United States."

Ellis Martin with Ken Aldrich of International Stem Cell Corporation (ISCO.OB)
Listen to full interview here: http://www.youtube.com/watch?v=WUyFYSGhNjc&feature=share or you can read a Transcript of the conversation here: http://www.ellismartinreport.com/node/148
(Scroll down to view this week's Radio Schedule for ISCO.)
“International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulletin Board and is based in Carlsbad, California where Ellis Martin had the pleasure of interviewing Executive Chairman Kenneth Aldrich.
International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISCO a unique leadership role in the field of regenerative cell therapy. Additionally, Lifeline Cell Technology, a wholly-owned subsidiary of International Stem Cell Corporation (ISCO) develops, manufactures and markets high-quality human primary cells, stem cells, media and reagents for sale to pharmaceutical, academic and government scientists.
The company's management pioneered the development of the normal human cell culture market through the creation of Clonetics® Corporation in the 1980s and has over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales of human cell culture products. Lifeline Cell Tech’s products are distributed in the United States and Europe.”


Monday, August 1st at 1:00pm

WVNJ-NY/NJ - AM1160      

Tuesday, August 2nd at 10:00am
KCEO - AM1000    
San Diego/Orange County/LA Beach Cities

Tuesday, August 2nd at 9:30am and Friday, August 5th at 3:30pm
WSBR-AM - 740 FM 95.5  
Boca Raton, West Palm Beach, Ft. Lauderdale, Miami

Mondays and Wednesdays at 1:00pm
WBNM-AM 1120
Boston and New England through: WESO AM 970 and WCRN AM 830
Ellis Martin Report
International Stem Cell Corporation
International Stem Cell Corporation is a paid sponsor of The Ellis Martin Report

Click here to listen to the entire interview: http://www.youtube.com/watch?v=WUyFYSGhNjc&feature=share

To Read More: International Stem Cell Corporation Chairman Ken Aldrich Interviewed by Ellis Martin
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation Chairman Ken Aldrich Interviewed by Ellis Martin | dataAugust 7th, 2011
Read All

Bill Lahti; stem cell nutrition stimulates wound repair for diabetic stroke victim

By Dr. Matthew Watson

Bill Lahti is experiencing a quality of life improvement using Stemenhance stem cell nutrition product to help support the body's natural renewal system of adult bone marrow stem cells helping his body to close an 3mm deep wound that was open for over 3 months.

Link:
Bill Lahti; stem cell nutrition stimulates wound repair for diabetic stroke victim

To Read More: Bill Lahti; stem cell nutrition stimulates wound repair for diabetic stroke victim
categoriaBone Marrow Stem Cells commentoComments Off on Bill Lahti; stem cell nutrition stimulates wound repair for diabetic stroke victim | dataAugust 6th, 2011
Read All

Spirulina DLA Naturals

By NEVAGiles23

http://www.facebook.com Spirulina is a powerful tonic for the immune system. In scientific studies, spirulina consistently improves immune system function and enhances the body's ability to generate new blood cells. The bone marrow stem cells, macrophages, T-cells and natural killer cells, exhibit enhaced activity, The spleen and thymus glands show enhanced funtion

Read more:
Spirulina DLA Naturals

To Read More: Spirulina DLA Naturals
categoriaBone Marrow Stem Cells commentoComments Off on Spirulina DLA Naturals | dataAugust 6th, 2011
Read All

Ying Liu discusses IPS cell therapy for ALS

By Dr. Matthew Watson

Ying Liu, a Scripps Clinic researcher in the lab of stem cell scientist Jeanne Loring, discusses the biological underpinnings of the technology for using induced pluripotent stem cells for treated ALS, or Lou Gehrig's disease. For more information about the Loring lab, go to http://www.scripps.edu

Read this article:
Ying Liu discusses IPS cell therapy for ALS

To Read More: Ying Liu discusses IPS cell therapy for ALS
categoriaIPS Cell Therapy commentoComments Off on Ying Liu discusses IPS cell therapy for ALS | dataAugust 6th, 2011
Read All

Stem Cell Therapy for Cerebral Palsy – Holly Catalano

By JoanneRUSSELL25

Holly is now able to crawl and sit up on her own just 7 weeks after her second treatment for cerebral palsy at the Stem Cell Institute in Panama City, Panama. Her physical therapist now says that Holly will walk without braces or a walker and her neurologist was very impressed by her overall decrease in tone since her return from Panama.

Visit link:
Stem Cell Therapy for Cerebral Palsy - Holly Catalano

To Read More: Stem Cell Therapy for Cerebral Palsy – Holly Catalano
categoriaUncategorized commentoComments Off on Stem Cell Therapy for Cerebral Palsy – Holly Catalano | dataAugust 3rd, 2011
Read All

Stem Cell Series: Part 1

By Dr. Matthew Watson

26-year old Jonathan Dieleman has an easy smile and a tireless work ethic. Raised on a cattle farm in Smithers, Jonathan was dirt biking last year when he hit a rock and broke his back. Jonathan was diagnosed a T-5 paraplegic - he couldn't move from the chest down

Read this article:

Stem Cell Series: Part 1

To Read More: Stem Cell Series: Part 1
categoriaUncategorized commentoComments Off on Stem Cell Series: Part 1 | dataJuly 31st, 2011
Read All

LifeCell in Kalaignar Seithigal,Sun News

By LizaAVILA

How stem cell banking saves a child's health forever? A news coverage on Kalaignar Seidhigal, Sun News and Jaya TV.

Excerpt from:

LifeCell in Kalaignar Seithigal,Sun News

To Read More: LifeCell in Kalaignar Seithigal,Sun News
categoriaBone Marrow Stem Cells commentoComments Off on LifeCell in Kalaignar Seithigal,Sun News | dataJuly 31st, 2011
Read All

Poor Diet May Make COPD Worse, Study Finds

By Dr. Matthew Watson

(HealthDay News) -- Certain vitamin deficiencies may lead to decreased lung function in people with chronic obstructive pulmonary disorder (COPD), which includes emphysema and chronic bronchitis, says a new study.

For the study, 20 COPD patients (13 women, seven men) completed a questionnaire to assess their dietary intake of vitamins A, C, D, E and selenium, all of which contain cell-protecting antioxidants. A diet low in antioxidants -- as compared to national dietary intake requirements -- was common among the patients.

The percentages of deficiencies were: 25 percent (selenium), 45 percent (vitamin C), 90 percent (vitamin E), 55 percent (vitamin A), and 70 percent (vitamin D).

The researchers then measured the maximum amount of air the patients could exhale with force. All the patients with a selenium-deficient diet had decreased lung function. Among patients deficient in vitamins C, A, and D, only men had decreased lung function. Read more...

Ayurtox for Body Detoxification

To Read More: Poor Diet May Make COPD Worse, Study Finds
categoriaIntegrative Medicine commentoComments Off on Poor Diet May Make COPD Worse, Study Finds | dataJuly 31st, 2011
Read All

IBN Develops New Genetic Engineering Technique To Treat Cancer Patients – Bernama

By Dr. Matthew Watson


Nanowerk LLC
IBN Develops New Genetic Engineering Technique To Treat Cancer Patients
Bernama
Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer ...
Insect Virus Holds the Key to Safer Stem Cell Therapy and could enable genetic ...Next Big Future

all 7 news articles »

To Read More: IBN Develops New Genetic Engineering Technique To Treat Cancer Patients – Bernama
categoriaUncategorized commentoComments Off on IBN Develops New Genetic Engineering Technique To Treat Cancer Patients – Bernama | dataJuly 31st, 2011
Read All

Novelist Featured in Monterey Herald on Eve of Carmel Book Event: Howard … – NewsReleaseWire.com (press release)

By Dr. Matthew Watson


NewsReleaseWire.com (press release)
Novelist Featured in Monterey Herald on Eve of Carmel Book Event: Howard ...
NewsReleaseWire.com (press release)
Birnberg's book is the first of the Catherine Fox Trilogy, all which take place 40-years in the future and involve the controversial topic of genetic engineering, what happens when it goes wrong and the societal implications involved in controlling or ...

To Read More: Novelist Featured in Monterey Herald on Eve of Carmel Book Event: Howard … – NewsReleaseWire.com (press release)
categoriaUncategorized commentoComments Off on Novelist Featured in Monterey Herald on Eve of Carmel Book Event: Howard … – NewsReleaseWire.com (press release) | dataJuly 31st, 2011
Read All

Slumdog to stardom: How Freida Pinto has adapted to the demands of fame – The Independent

By Dr. Matthew Watson


MTV.com
Slumdog to stardom: How Freida Pinto has adapted to the demands of fame
The Independent
Via genetic engineering, he's trying to find a cure for Alzheimer's – a goal that goes from professional quest to personal odyssey as his father (played by John Lithgow) gradually succumbs to the disease. In the course of his experiments, ...
Movies Coming SoonSouth Bend Tribune
Six New Clips from Rise of the Planet of the ApesShockya.com
Freida Pinto - Freida Pinto Steals The Show At 'Apes' PremiereContactmusic.com
International Business Times -The Sun
all 148 news articles »

To Read More: Slumdog to stardom: How Freida Pinto has adapted to the demands of fame – The Independent
categoriaUncategorized commentoComments Off on Slumdog to stardom: How Freida Pinto has adapted to the demands of fame – The Independent | dataJuly 31st, 2011
Read All

Page 724«..1020..723724725726..730740..»


Copyright :: 2025